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ABSTRACT
Novel triazolium, imidazolium, and benzimidazolium salts are known to possess
anti-cancer properties and have potential as cancer therapeutics. This thesis describes
the aqueous solubility and the differential activity of N,AT-bis-substituted-l,2,4triazolium bromide salts and N/N'-bis(naphthylmethyl)imidazolium bromide salts
against MDA-MB-468 breast cancer cells and PC-3 prostate carcinomas. Using a
microscale technique, the partition coefficient (log P) of each salt was determined. The
log P value was explored to determine the bioavailability of each derivative.
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Figure 1: Triazole and Imidazole Compounds. Triazoles are heterocyclic compounds containing
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Figure 4. Partition Coefficient of Synthesized Compounds. Compound identification:

Compound 1 (Dark blue), Compound 2 (Crosshatched), Compound 3 (Medium blue)
Compound 4 (Diagonal lines), and Compound 5 (Light blue with dark outline). The
octanol/water coefficient of compounds 1-5 was determined in a microscale assay.
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Figure 5. Proliferation of MDA-MB-468 Breast Cancer Cells Treated with 1-5. Coloring is the

same as Figure 4. Compounds 1 and 3 had very little anti-proliferative effects even at 30
pM. Compounds 2, 4, and 5 showed similar anti-proliferative effects at 30 pM.19
Figure 6. Proliferation of PC-3 Prostate Cancer Cells Treated with 2, 4, and 5. Coloring is the

same as Figure 5. In contrast to activity against the breast cancer cell line, Compound 2
exhibited very low activity against the prostate cancer cell line. In contrast, 4 and 5
showed similar anti-proliferative effects against both cancer types.20
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I.

Cancer
Cancer is a devastating disease that effects over 1.5 million people each year and

the annual death toll exceeds 550,000 deaths making it the second leading cause of
death in the United States.12 Cancer is also one of the leading causes of death
worldwide. It contributed to 8.2 million deaths in 2012.3 Due to its prevalence, an
enormous amount of funding is dedicated to establishing treatments and cures.
Cancer is characterized by deregulated cell proliferation. The rapidly dividing
cells require several biomolecules, including fatty acids and membrane lipids, to fulfill
their needs.4 Cancer has various forms and can begin in any part of the body. Left
untreated, malignant cancers can metastasize. When cancer metastasis occurs,
cancerous cells have the potential to compromise the integrity of other organ systems
within the body and lead to death.

II.

Triazolium and Imidazolium Salt Derivatives
Cell-specific cancer treatments exist only for a few cancers.5 Traditional

chemotherapies tend to lack cell-specificity, which leads to the damage of healthy cells.
Imidazole and triazole based compounds have long garnered attention for their cancer
killing potential, and their salt derivatives have been shown to possess selective
anticancer properties.6,7 A recent study presented a novel 1,2,3-triazolium salt that
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arrested the growth of the drug resistant 7T subline of laryngeal carcinoma HEp-2 cells.8
Another study has shown that a series of imidazolium salts were found to be
selectively toxic to two highly tumorigenic breast cancer cell lines and not to normal
breast cells.9

Figure 1: Triazole and Imidazole Compounds. Triazoles are heterocyclic compounds

containing three nitrogen atoms. The five membered rings can have four structures
(Left to right: 1H-1,2,3-Triazole; 2H-1,2,3-Triazole; 1H-1,2,4-Triazole; 4H-1,2,4Triazole). Imidazole (far right) is a heterocyclic compound with two nitrogen atoms.

Triazoles are heterocyclic compounds containing three nitrogen atoms. The five
membered rings can have four structures (Figure 1). Imidazole is also a heterocyclic
five-membered ring, but with two nitrogen atoms (Figure 1). Heterocyclic compounds
are key components of many biologically active compounds. The imidazole ring is a
constituent of purine, histamine, histidine, and nucleic acid bases.10 In addition, the
heterocyclic composition of triazole derivatives garners biological significance as they
can have many biological properties such as serving as selective adenosine receptor
agonists and antagonists.11

Page 14

Due to the poor solubility of triazole and imidazole compounds, most studies
have utilized the ionic form of these heterocyclic rings. Both imidazole and triazole
have weakly acidic protons and can undergo deprotonation upon treatment with a
strong base. Alternatively, di-substitution produces the cationic forms (Figure 2).

Figure 2. N,N'-bis-substituted 1,2,4-triazolium and imidazolium cations. 1,2,4-

triazolium (left) and imidazolium (right) cations formed by di-substitution.

Numerous studies have highlighted the importance of the substituent structure
in determining the physical and chemical properties of the resulting triazolium and
imidazolium salts.8 Using this information, a set of N,N'-bis-substituted-l,2,4-triazolium
bromide salts (1 - 3, Figure 3) were synthesized and tested for anti-proliferative activity
against MDA-MB-468 breast cancer cells and PC-3 prostate cancer cells. These novel
1,2,4-triazolium salts (1 - 3) were also tested against previously reported imidazolium
salts (4 and 5) to determine the role of the parent compound (i.e. imidazole, triazole,
benzimidazole) on aqueous solubility and activity.
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Figure 3. Schematic representation of N,AT-bis-substituted-l,2,4-triazolium bromide
salts (1-3), N,N'-bis(naphthylmethyl)imidazolium bromide (4) and N,N'~
bis(naphthylmethyl)benzimidazolium bromide (5) compounds.

The novel compounds (1-3) exhibited a range of anti-proliferative activities.
However, it was unclear if differential activity was due to modified receptor-ligand
interactions or a result of altered solubility and bioavailability. Rational drug design is
complicated by the need to balance many stringent and often competing requirements.
In order for a molecule to have biological activity, it must have a chemical structure that
is complimentary to its target. However, even the most potent drug is useless if it
cannot reach its target. Often this means the compound must have an aqueous
solubility high enough to allow transport via the bloodstream, yet still retain sufficient
lipophilic character to cross the cellular membrane. Modification of potential drug
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candidates has the potential to change any or all of these properties. Therefore, it was
important to determine if the differential activity exhibited by compounds 1-3 was a
result of altered hydrophilicity/lipophilicity or altered molecule-target interactions.

III.

Partition Coefficient and log P
The chemical and biophysical properties, such as permeability of the lipid bilayer

membrane, is altered significantly in many pathogenic cells such as cancer.12 Therefore,
the balance between hydrophilic and lipophilic character must be optimized to allow
for both distribution and uptake. The partition coefficient, which describes the
partitioning of a solute between an organic and an aqueous phase, is used extensively in
medicinal chemistry and drug design.13 In this study, the octanol/water partition
coefficient (Kow) was utilized. The octanol/water partition coefficient is Kow, see
Equation 1.

^ow

final concentration in octanol layer _ C0f
final concentration in aqueous layer CWf

^^^

Taking the mathematical logarithm of Kow yields the log P value. The log P
values are weakly dependent on solute concentration and highly dependent on
temperature. It is also important to note that reported Kow and log P values often vary
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due to experimental differences. Therefore, rigorous comparison of these values for
different compounds is only possible within a given data set. It is strongly advised that
values from different experiments should not be directly compared.
Despite the variability in reported values, log P has been traditionally used to
inform the rational design of compounds targeted for biological use. The most
commonly reported values reflect the use of octanol as an approximation of the lipid
bilayer that surrounds all cells.
It has been proposed that novel drugs which can exploit the differences between
cancer and healthy cells may be a route to selective anti-cancer treatments. The log P
value of new drugs offers an insight in the development of target-oriented cancer
therapies.
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A. Materials
Triazolium and imidazolium compounds. All reagents and solvents used in the
synthesis of compounds 1-5 were purchased from commercial sources and used
without purification. Compounds 1-5 were provided by the Taylor Lab.
Partition Coefficients. Octanol and dimethyl sulfoxide were purchased from Sigma
Aldrich. The following instruments were used: a Thermo Fisher Genesys 10s UV-Vis
spectrophotometer, a Sorvall Lynxx 4000 Superspeed Centrifuge, a Thermo Micro 17
Microcentrifuge, and a 700-pL quartz cuvette (Thor Labs).
Cell Culture. MDA-MB-468 breast cancer cells and PC-3 prostate cancer cells
(ATCC) were grown in L-15 and DMEM/F12K media supplemented with 10% FBS and
1% antibiotic/antimycotic. PC-3 cells were grown in 5% CO2 incubator at 37°C. MDAMB-468 cells were grown in the absence of CO2 at 37°C. Media was replaced every 3
days and split once 80% confluency was reached.
MTT assays. Cells were plated in triplicate at lxlO6 cells/mL with 0.1 mL per well
in 96-well plates and allowed to adhere overnight. After 24 h incubation, media was
removed, and cells were treated with 0,1, 5,15 and 30 pM of compounds 1-5
solubilized

in fresh complete growth media for 72 h at 37°C. After incubation, MTT

reagent (ATCC) was added to each well and returned to the incubator for 4 h at 37°C to
produce formazan crystals in the dark. Next, MTT detergent was added to solubilize
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crystals and incubated for another 2 h in the dark. Absorbance was read at 570 nm with
a reference wavelength of 655 nm.

B. Determination of Lambda Max (Amax)
The lambda max represents the wavelength at which a compound absorbs the
maximum light. To scan for the lambda max of each compound, very dilute samples of
1-5 were prepared in dH20 and the absorbance spectrum from 200 — 300 nm was

measured. After scanning each compound, the lambda max for each compound was
measured to be close to or at 223 nm. Therefore, all absorbance measurements were
conducted at 223 nm.

C. Determination of Linear Range
Molar absorption coefficients (8) for the novel N,N'-bis-substituted-l,2,4triazolium bromide salts (1-3) and N,N'-bis(naphthylmethyl)imidazolium bromide salts
(4 and 5) compounds were not directly measured. However, the linear range for

absorbance vs. concentration was determined. Each compound was dissolved in a 50
mL centrifuge tube with dH20. If the compound did not dissolve completely, a 1 mL
aliquot was placed in a 1.5 mL microcentrifuge tube and centrifuged for 5 minutes at
max speed in the Sorvall Lynxx 4000 Superspeed Centrifuge. The supernatant was
pipetted to a new 1.5 mL microcentrifuge tube. The absorbance of the supernatant was
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measured at 223 nm. The solutions were diluted, and the absorbance measured until
there was a direct correlation between dilution factor and absorbance. It was
determined that concentrations that produced an absorbance around 0.500 were in the
linear range for all compounds.

D. Preparation and Measurement of Partition Coefficients
To determine the log P value of each compound, a microscale approach using 1.5
mL microcentrifuge tubes was utilized. Each log P measurement was performed in
triplicate. Briefly, 700 [iL of octanol and 700 fj.L of the water dissolved compound were
vigorously mixed using a lab mixer. Each sample was then allowed to fully equilibrate
overnight. The next day, each sample was briefly centrifuged using a Thermo Micro 17
Microcentrifuge to further aid separation of the solvent layers. Then 300 i^L of the top
octanol layer was removed and placed into a separate 1.5 mL microcentrifuge tube to
avoid any overspill caused by volume displacement upon pipette tip insertion.
Immediately, 300 yuL from the very bottom of the aqueous layer were removed,
avoiding any octanol contamination, and placed into a separate 1.5 mL microcentrifuge
tube. Then this sample was diluted with 200 /rL of water and mixed briefly before the
absorbance at 223 nm was measured. The absorbance of the compound in the aqueous
layer before and after incubation with octanol was used to determine the Kow and log P
values for each compound.
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E. Calculations

Due to time constraints, it was impractical to fully explore the changes in the UV
absorbance spectrum for each compound in both water and octanol. Therefore, all
characterization was carried out on the aqueous layer. The law of conservation of mass,
along with Beer's Law, makes it possible to calculate the concentration of samples in the
octanol layer by measuring the change in concentration in the aqueous layer. The
partition coefficient is the ratio of the final concentration of the compound in octanol
([C]0/) and the final concentration of compound in the aqueous layers ([C]w/) as seen
in Equation 1.
[C]of
[C]wf

(1)

Mass conservation means that the amount of compound that enters the octanol
layer (AM0) can be determined by measuring the amount of compound lost from the
aqueous layer (—AMw, Equation 2).
AM0 = -AMw

(2)

The mass (m) of a compound present is directly related to the volume (V), molar
concentration [C] and molecular weight (MW).
m — [C] * MW *V

(3)

We can determine the change in mass by combining Equations 2 and 3 to give
Equation 4.
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A([C]0 * MW * V0) = -A([C]W * MW * Vw)

(4)

Under conditions in which the molecular weight does not change and the
volume of the two solvents are equal, the equation can be simplified, as shown in
Equation 5.

A[C]0 = —A[C]W

(5)

Given the situation where initial concentration of compound in the octanol is
zero, the change in compound concentration is simply equal to the final concentration
(Equation 6).

A[C]„ = ([C]0/ - [CJoi) = ([CW - 0) = [C]„,

(6)

Combining Equations 5 and 6 gives us the final compound concentration in the
octanol layer in terms of the compound concentration in the water layer (Equation 7).

[C]of = -A [C]w

(7)

The partition coefficient equation can now be written in terms of the compounds
concentration in the water level (Equation 8).

_ [C]of _ ~A[C]W
°W
[C]wf
[C]wf
( ;
Beer's Law relates the light absorbance (A) of an analyte to the molar absorption
coefficient (e), the length of the light traveled through the sample (l), and the molar
concentration of the analyte (Equation 9).

A = sCl

-

(9)
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Rearrangement allows the concentration to be determined when the absorbance
is known, assuming that the molar absorption coefficient is not zero (Equation 10).

The variable of concentration can be substituted into the partition coefficient
Equation 8, to give Equation 11.

11)

Since all measurements are of the water layer, the molar absorption coefficient is
constant. Likewise, the path length is a constant. Therefore, the partition coefficient can
be determined directly from the absorbance values (Equation 12).

(12)
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VI.

Results and Discussion
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A. Partition Coefficient (log P) Analysis
The partition coefficient of each novel triazolium salt 1-3, imidazolium salt 4, and
benzimidazolium salt 5 derivative is shown in Figure 4. Compound 1 exhibited the
highest aqueous solubility among all salt derivatives and would have the greatest
bioavailability. Compound 5 exhibited the greatest octanol solubility among the salt
derivatives and would have the lowest bioavailability. Compounds 2-4 exhibited
variability in solubility and bioavailability.

Partition Coefficients (Log P) of Synthesized
Compounds
2

Figure 4. Partition Coefficient of Synthesized Compounds. Compound identification:
Compound 1 (Dark blue), Compound 2 (Crosshatched), Compound 3 (Medium blue)
Compound 4 (Diagonal lines), and Compound 5 (Light blue with dark outline). The
octanol/water coefficient of compounds 1-5 was determined in a microscale assay.
Positive Log P values represent an increased affinity for the octanol layer.
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B. MDA-MB-468 Breast Cancer Cell Proliferation Assay

Once the partition coefficient of each novel compound was determined, a
proliferation assay was conducted on MDA-MB-468 breast cancer cells to distinguish
the correlation between the determined partition coefficients and effectiveness in
reducing cancer cell proliferation rates. Compound 1 exhibited very poor anti¬
proliferative activity against MDA-MB-468 breast cancer cells with more than 70%
proliferation at 30 pM (73% ±19%, Figure 5) despite favorable water solubility (log P =
-1.88 ±0.05, Figure 4). The analogous bis(naphthylmethyl)triazolium salt 2 was
synthesized and exhibited a substantial increase in anti-proliferative activity above 15
pM and less than 15% proliferation at 30 pM (9% ±4%). However, the increase in
activity came at the expense of solubility (log P = 0.17 ±0.01). To regain some solubility,
the 1,2,4-triazolium salt 3, containing the naphthylacetyl substituent, was synthesized
and tested. However, water solubility did not increase (log P = 0.6 ±0.1), and the activity
was all but eliminated with greater than 80% proliferation remaining at 30 pM.
Compounds 4 and 5, through their rigid ring structures, have been shown to have anti¬
proliferative activity against several non-small cell cancer cell lines.14-15 Unsurprisingly,
the imidazolium and benzimidazolium salt derivatives (4 and 5, respectively) showed
similar anti-proliferation effects in the breast cancer cell assays. This anti-proliferative
activity was present despite the unfavorable water solubility in 4 (log P = 0.73 ±0.08) and
5 (log P = 1.3 ±0.3).
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After conducting the MDA-MB-468 breast cancer cell proliferation assay, it was
seen that 2 exhibited similar effects on cell proliferation much like that of 4 and 5 at 30
pM, but not at lower concentrations. The similar anti-proliferative effect of 2 was at a 4fold increase in water solubility (log P = 0.17 ±0.01) compared to 4 (log P = 0.73 ±0.08)
and 5 (log P = 1.3 ±0.3). This increased solubility was due to the introduction of the
additional unsubstituted nitrogen. The marked differences in activity of 2 at lower
concentrations suggests that modification of the parent core may impact solubility more
drastically than anti-cancer activity. It also suggests that using the triazolium
heterocycle as the parent compound may provide a route to superior bioavailability by
increasing hydrophilic character without modifying the crucial naphthylmethyl
substituents.
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Proliferation of MDA-MB-468 Breast Cancer Cells
120%

OpM

l|iM

5pM

15|iM

30pM

Concentration of Compound in Assay

Figure 5. Proliferation of MDA-MB-468 Breast Cancer Cells Treated with 1-5.
Coloring is the same as Figure 4. Compounds 1 and 3 had very little anti-proliferative
effects even at 30 pM. Compounds 2, 4, and 5 showed similar anti-proliferative effects
at 30 pM.

C. PC-3 Prostate Cancer Cell Proliferation Assay

To determine the effectiveness of 2 on additional cancers, its activity against PC-3
prostate cancer cells was compared to 4 and 5. Compounds 4 and 5 have previously
been shown to exhibit similar activity against several non-small cell cancer cell lines.14'15
Unsurprisingly, the imidazolium and benzimidazolium salt derivatives (4 and 5,
respectively) showed similar anti-proliferation effects in both the breast and prostate
cancer assays. Interestingly, the triazolium salt 2 had a marked decrease in effectiveness
against the prostate cells with more than 70% proliferation at 30 pM (75% ±4%, Figure 6)
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compared to 9% ±4% for the breast cancer cell line. This apparent differential activity
suggests that modification of the parent heterocycle may provide a route to cell
selective anti-cancer compounds.

Proliferation of PC-3 Prostate Cancer Cells
120

Concentration of Compound in Assay

Figure 6. Proliferation of PC-3 Prostate Cancer Cells Treated with 2, 4, and 5.
Coloring is the same as Figure 5. In contrast to activity against the breast cancer
cell line, compound 2 exhibited very low activity against the prostate cancer cell
line. In contrast, 4 and 5 showed similar anti-proliferative effects against both
cancer types.
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D. Correlation of Aqueous Solubility and Anti-Cancer Activity
The partition coefficient provides insight into the aqueous solubility and
potential bioavailability of novel compounds. The lower or more negative a partition
coefficient is, the greater the aqueous solubility. On the other hand, the greater or more
positive a partition coefficient is, the greater the lipophilicity or hydrophobic solubility.
A drug's bioavailability is typically increased by increasing its aqueous solubility.
However, an increase in bioavailability is not always correlated with a decrease in
cancer cell proliferation rates as can be seen from the MDA-MB-468 breast and PC-3
prostate cancer cell proliferation assays in Figure 5 and 6, respectively.
When comparing aqueous solubility of 1 (log P = -1.88 ±0.05) to 2 (log P = 0.17
±0.01), 1 would have a greater bioavailability in comparison to 2, due to its greater
aqueous solubility. However, increased bioavailability does not always correlate with
decreased cancer cell activity and proliferation. Cancer drugs can trigger apoptosis in
cancer cells via binding to surface receptors or diffusing into the cells. These two factors
are significantly affected by both a compound's structure and solubility. That is, if a
compound does not exhibit the proper structural domains/functional groups necessary
to trigger programmed cell death, even if soluble, apoptosis will not occur. Therefore,
this explains the observation between the triazolium salt compounds 1 and 2. Although,
1 had greater bioavailability due to its increased aqueous solubility, it did not have the
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VII.

Conclusion and future work

This study was conducted to determine the correlation of aqueous solubility and
anti-cancer activity of novel triazolium, imidazolium, and benzimidazolium salt
derivatives through determination of their partition coefficient. It was determined that
the triazolium salts 1 and 3, did not exhibit any significant anti-proliferative cancer
activity. However, the triazolium salt 2, in comparison to the imidazolium salts 4 and 5,
demonstrated similar anti-proliferative activity against the MDA-MB-468 breast cancer
cell line at an increased aqueous solubility. The same anti-proliferative activity against
the PC-3 prostate cancer cell line was not observed in 2. The marked selectivity of 2,
indicates that related triazolium salt derivatives may provide a route to increased
aqueous solubility and selective anti-cancer activity.
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Appendix

I.

A

Amax

[C]

Abbreviations

absorbance

Lambda Max

concentration of compound

logP

Partition Coefficient

MDA-MB-468

M

breast cancer cell line

molarity of compound

concentration in octanol

M0

molarity of compound in octanol

[C]oi

initial concentration in octanol

Mw

molarity of compound in water

[Qof

final concentration in octanol

mL

milliliters

[C]w

concentration in water

nm

nanometers

[C]wi

initial concentration in water

[C]w/

final concentration in water

pL

cLH20

distilled water

UV

[C]o

£

Kow

1

PC-3

prostate cancer cell line

microliters

Ultraviolet

molar absorption coefficient

V

volume

octanol/water constant

Vn

volume of octanol
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volume of water
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